Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Mar;102(3):306–309. doi: 10.1289/ehp.94102306

Application of reliability models to studies of biomarker validation.

E Taioli 1, P Kinney 1, A Zhitkovich 1, H Fulton 1, V Voitkun 1, G Cosma 1, K Frenkel 1, P Toniolo 1, S Garte 1, M Costa 1
PMCID: PMC1567110  PMID: 8033872

Abstract

We present a model of biomarker validation developed in our laboratory, the results of the validation study, and the impact of the estimation of the variance components on the design of future molecular epidemiologic studies. Four different biomarkers of exposure are illustrated: DNA-protein cross-link (DNA-PC), DNA-amino acid cross link (DNA-AA), metallothionein gene expression (MT), and autoantibodies to oxidized DNA bases (DNAox). The general scheme for the validation experiments involves n subjects measured on k occasions, with j replicate samples analyzed on each occasion. Multiple subjects, occasions, and replicates provide information on intersubject, intrasubject, and analytical measurement variability, respectively. The analysis of variance showed a significant effect of batch variability for DNA-PC and MT gene expression, whereas DNAox showed a significant between-subject variability. Among the amino acids tested, cysteine and methionine showed a significant contribution of both batch and between-subject variability, threonine showed between-subject variability only, and tyrosine showed between-batch and between-subject variability. The total variance estimated through the experiment was used to calculate the minimum sample size required for a future epidemiologic study including the same biomarkers used for the reliability study. Such validation studies can detect the various components of variability of a biomarker and indicate needed improvements of the assay, along with possible use in field studies.

Full text

PDF
306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cosma G. N., Currie D., Squibb K. S., Snyder C. A., Garte S. J. Detection of cadmium exposure in rats by induction of lymphocyte metallothionein gene expression. J Toxicol Environ Health. 1991 Sep;34(1):39–49. doi: 10.1080/15287399109531547. [DOI] [PubMed] [Google Scholar]
  2. Frenkel K., Karkoszka J., Kim E., Taioli E. Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Radic Biol Med. 1993 May;14(5):483–494. doi: 10.1016/0891-5849(93)90105-4. [DOI] [PubMed] [Google Scholar]
  3. Griffith J., Duncan R. C., Hulka B. S. Biochemical and biological markers: implications for epidemiologic studies. Arch Environ Health. 1989 Nov-Dec;44(6):375–381. doi: 10.1080/00039896.1989.9935910. [DOI] [PubMed] [Google Scholar]
  4. Hatch M. C., Friedman-Jimenez G. Using reproductive effect markers to observe subclinical events, reduce misclassification, and explore mechanism. Environ Health Perspect. 1991 Jan;90:255–259. doi: 10.1289/ehp.90-1519471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hulka B. S. ASPO Distinguished Achievement Award Lecture. Epidemiological studies using biological markers: issues for epidemiologists. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec;1(1):13–19. [PubMed] [Google Scholar]
  6. Lin X., Zhuang Z., Costa M. Analysis of residual amino acid--DNA crosslinks induced in intact cells by nickel and chromium compounds. Carcinogenesis. 1992 Oct;13(10):1763–1768. doi: 10.1093/carcin/13.10.1763. [DOI] [PubMed] [Google Scholar]
  7. Rothman N., Stewart W. F., Caporaso N. E., Hayes R. B. Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):299–303. [PubMed] [Google Scholar]
  8. Schatzkin A., Freedman L. S., Schiffman M. H., Dawsey S. M. Validation of intermediate end points in cancer research. J Natl Cancer Inst. 1990 Nov 21;82(22):1746–1752. doi: 10.1093/jnci/82.22.1746. [DOI] [PubMed] [Google Scholar]
  9. Schulte P. A. Methodologic issues in the use of biologic markers in epidemiologic research. Am J Epidemiol. 1987 Dec;126(6):1006–1016. doi: 10.1093/oxfordjournals.aje.a114740. [DOI] [PubMed] [Google Scholar]
  10. Zhitkovich A., Costa M. A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo. Carcinogenesis. 1992 Aug;13(8):1485–1489. doi: 10.1093/carcin/13.8.1485. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES